5791 - 5800 of 7665 Results
Title
Year
- The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease2017RESTRICTEDTitle: The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 291Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2017.01.012Citation Count: 18
-
RESTRICTEDTitle: GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2Journal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 26Issue #: 14Start Page: 2747End Page: 2767Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddx161Best OA location URL: https://academic.oup.com/hmg/article-pdf/26/14/2747/24340312/ddx161.pdfCitation Count: 63
- The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK22017RESTRICTEDTitle: The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1547End Page: 1558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bcj20160909Best OA location URL: https://europepmc.org/articles/pmc6178381?pdf=renderCitation Count: 32
-
RESTRICTEDTitle: The PINK1 p.I368N mutation affects protein stability and ubiquitin kinase activityJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0174-zBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0174-zCitation Count: 63
-
RESTRICTEDTitle: Endoplasmic reticulum proteostasis impairment in agingJournal Name: Aging CellPublisher: WileyVol: 16Issue #: 4Start Page: 615End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.12599Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.12599Citation Count: 166
- Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathway2017RESTRICTEDTitle: Whole transcriptome profiling of the human hippocampus suggests an involvement of the KIBRA rs17070145 polymorphism in differential activation of the MAPK signaling pathwayJournal Name: HippocampusPublisher: WileyVol: 27Issue #: 7Start Page: 784End Page: 793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/hipo.22731Best OA location URL: https://europepmc.org/articles/pmc5501956?pdf=renderCitation Count: 19
-
RESTRICTEDTitle: Imaging genetics approach to Parkinson’s disease and its correlation with clinical scoreJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/srep46700Best OA location URL: https://doi.org/10.1038/srep46700Citation Count: 14
- Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress2017RESTRICTEDTitle: Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stressJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-017-0862-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-017-0862-1Citation Count: 24
- An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression2017RESTRICTEDTitle: An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 11Issue #: 7-8Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/prca.201700045Best OA location URL: https://europepmc.org/articles/pmc5540649?pdf=renderCitation Count: 13
- Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)2017RESTRICTEDTitle: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013Citation Count: 0